JCHOR

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.

EndNote Style
Index

Current Issue 2025/3/3

Original Article
Evaluation of treatment regimens and prognostic factors in primary central nervous system lymphomas

Published: 08 Aug 2025

Citation: Akdeniz N, Ebinç S, Barışta İ, et al. Evaluation of treatment regimens and prognostic factors in primary central nervous system lymphomas. J Curr Hematol Oncol Res. 2025;3(3):49-56.

Original Article
Ten-year journey with myelofibrosis: real-world data and clinical outcomes from a tertiary care center

Published: 08 Aug 2025

Citation: Balık B, Akdeniz A, Koyuncu MB, et al. Ten-year journey with myelofibrosis: real-world data and clinical outcomes from a tertiary care center. J Curr Hematol Oncol Res. 2025;3(3):57-61.

Original Article
Prognostic factors in diffuse large B cell lymphoma: a retrospective analysis from a tertiary center

Published: 08 Aug 2025

Citation: Kahraman S, Doğan A, Çelik S, Esen R, Yıldırım Doğan N. Prognostic factors in diffuse large B cell lymphoma: a retrospective analysis from a tertiary center. J Curr Hematol Oncol Res. 2025;3(3):62-66.

Review
The role of ELABELA in targeted treatment of acute myeloid leukaemia

Published: 08 Aug 2025

Citation: Yanardağ Açık D, Karabulut ZT. The role of ELABELA in targeted treatment of acute myeloid leukemia. J Curr Hematol Oncol Res. 2025;3(3):67-73.

Case Report
A rare case report: cytarabine-induced skin rash

Published: 08 Aug 2025

Citation: Gülsar Çaycı MG, Satılmış O, Demircioğlu S, Tekinalp A. A rare case report: cytarabine-induced skin rash. J Curr Hematol Oncol Res. 2025;3(3):74-76.

Most Read Articles

Original Article
ß-catenin expression in myelodysplastic syndromes and myeloproliferative neoplasms in bone marrow, in relation to CD34 and CD117 status

Published: 30 Aug 2023

Citation: Barış Iİ, Büyükbayram H. ß-catenin expression in myelodysplastic syndromes and myeloproliferative neoplasms in bone marrow, in relation to CD34 and CD117 status. J Curr Hematol Oncol Res. 2023;1(3):54-58.

Original Article
Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID 19 antibody level in hematological patients

Published: 26 Feb 2023

Citation: Kaya A, Berber İ, Kuku İ, et al. Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID-19 antibody level in hematological patients. J Curr Hematol Oncol Res. 2023; 1(1): 1-4

Review
Chronic lymphocytic leukemia

Published: 30 Aug 2023

Citation: Fidan K. Chronic lymphocytic leukemia. J Curr Hematol Oncol Res. 2023;1(3):59-67.

_Footer